tiprankstipranks
Trending News
More News >
Owlet (OWLT)
NYSE:OWLT
US Market
Advertisement

Owlet (OWLT) AI Stock Analysis

Compare
94 Followers

Top Page

OW

Owlet

(NYSE:OWLT)

Rating:73Outperform
Price Target:
$10.50
▲(29.31%Upside)
Owlet's overall stock score is driven primarily by strong technical analysis and positive earnings call sentiment. Despite significant financial challenges and valuation risks, recent strategic initiatives and operational successes provide optimism for future performance. However, the company's financial instability remains a critical area to address.
Positive Factors
Earnings
OWLT delivered a strong first quarter, beating revenue and adjusted EBITDA estimates.
Partnerships
OWLT announced a new partnership with the Children's Hospital of The King's Daughter, allowing babies to leave the hospital with an OWLT monitor.
Product Adoption
Owlet dominates the smart baby monitor segment, being the first and only FDA-cleared smart baby monitors presently on the market.
Negative Factors
Gross Margin
Management lowered the gross margin guide due to tariff concerns.

Owlet (OWLT) vs. SPDR S&P 500 ETF (SPY)

Owlet Business Overview & Revenue Model

Company DescriptionOwlet, Inc. operates as a digital parenting platform in the United States. The company's platform focuses on giving real-time data and insights to parents. Its products include Smart Sock, a baby monitor to track an infant's oxygen levels, heart rates, and sleep trends; Dream Sock, an app to assist children for better sleep; Cam, a video streaming app to hear and see baby from anywhere; and Dream Lab, an interactive online platform that assists families in building healthy sleep habits. The company also offers Dream Duo, a monitoring system for baby's sleeping habits and includes wearable sock monitor, HD video, and digital sleep coach. Owlet, Inc. was founded in 2012 and is based in Lehi, Utah.
How the Company Makes MoneyOwlet makes money primarily through the sale of its Smart Sock and other related products, such as the Owlet Cam, which provides HD video streaming and audio monitoring for parents. The company generates revenue by selling these products directly through its website and through various retail partners. Owlet also offers subscription services that provide users with enhanced features, such as historical data tracking and personalized insights. Significant partnerships with distributors and retailers help expand its market reach, contributing to its revenue streams. Additionally, Owlet invests in research and development to continually innovate and introduce new products, which supports ongoing sales growth.

Owlet Earnings Call Summary

Earnings Call Date:May 08, 2025
(Q1-2025)
|
% Change Since: 94.72%|
Next Earnings Date:Aug 07, 2025
Earnings Call Sentiment Positive
The earnings call conveyed a positive sentiment, with strong revenue growth, improved margins, successful product adoption, and strategic partnerships outweighing challenges from tariffs and litigation costs.
Q1-2025 Updates
Positive Updates
Revenue Growth
Revenue for Q1 2025 was $21.1 million, marking a 43% increase year-over-year, driven by strong sales of Dream Sock and Dream Duo.
Gross Margin Improvement
The gross margin improved by 930 basis points year-over-year to 53.7%, marking the eighth consecutive quarter of gross margin expansion.
Owlet 360 Subscription Success
Owlet 360 has over 48,000 paying subscribers since its launch on January 28th, indicating strong adoption and contributing positively to the business.
Strategic Partnerships
A new distribution partnership with Children’s Hospital of the King’s Daughters allows babies to leave the hospital with an Owlet monitor, marking a significant milestone.
International Expansion
International revenue grew by 104% year-over-year, with significant growth in France and Germany.
Financial Performance
Owlet achieved breakeven adjusted EBITDA for the fourth consecutive quarter, with a $3.1 million improvement year-over-year.
Negative Updates
Tariff Challenges
Newly implemented 10% tariffs on imports from Thailand and Vietnam impact gross margin expectations, though the company has eliminated material exposure to China tariffs.
Litigation Settlement Costs
Operating expenses increased due to $0.9 million one-time litigation settlement costs related to a shareholder derivative suit.
Company Guidance
During the Owlet Q1 2025 Earnings Conference Call, the company reported robust financial performance, surpassing expectations with a 43% year-over-year revenue growth, amounting to $21.1 million. This growth was driven by strong sales of their Dream Sock and Dream Duo products, as well as early success with their Owlet 360 subscription service, which had over 48,000 paying subscribers. The company achieved a gross margin of 53.7%, marking their eighth consecutive quarter of year-over-year gross margin expansion. Despite a challenging macroeconomic environment, Owlet maintained breakeven adjusted EBITDA for the fourth consecutive quarter, improving by $3.1 million year-over-year. As a result of the strong start to the year, Owlet raised its full-year revenue guidance to between $91 million and $95 million, anticipating 17% to 22% growth. The company also highlighted strategic partnerships, including a new distribution agreement with Children’s Hospital of the King’s Daughters, and continued international expansion with revenue growth of 104% year-over-year in international markets.

Owlet Financial Statement Overview

Summary
Owlet faces significant financial challenges, with persistent net losses, negative equity, and cash flow issues. Recent revenue growth and improvements in EBITDA provide some optimism, but high liabilities and negative cash flows remain critical concerns. External financing efforts indicate a strategy to maintain liquidity amidst these challenges.
Income Statement
45
Neutral
Owlet's revenue shows inconsistency, with recent growth from 2023 to TTM after a dip. However, persistent negative net income and negative EBIT margins indicate ongoing profitability issues. The company has shown some improvement in EBITDA, suggesting potential for operational efficiency gains.
Balance Sheet
30
Negative
The balance sheet reveals significant challenges, with negative stockholders' equity indicating potential solvency issues. The debt-to-equity ratio calculation is not feasible due to negative equity, but the high total liabilities relative to assets suggest financial instability.
Cash Flow
40
Negative
Free cash flow remains negative, indicating ongoing liquidity challenges. The operating cash flow to net income ratio is negative, highlighting inefficiencies in translating revenue into cash. Despite these challenges, there is a positive trend in financing cash flow, reflecting efforts to bolster liquidity through external funding.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue78.06M54.01M69.20M75.80M75.40M
Gross Profit39.31M22.59M23.30M35.00M35.88M
EBITDA-9.47M-27.49M-75.53M-42.71M-8.25M
Net Income-12.54M-32.90M-79.29M-98.17M-10.52M
Balance Sheet
Total Assets49.52M44.12M58.10M140.00M40.12M
Cash, Cash Equivalents and Short-Term Investments20.25M16.56M11.20M95.10M17.01M
Total Debt11.70M15.22M16.30M16.50M28.84M
Total Liabilities66.33M73.80M68.70M84.80M60.94M
Stockholders Equity-16.81M-29.68M-10.60M55.20M-20.82M
Cash Flow
Free Cash Flow-11.97M-23.59M-82.97M-42.62M-1.19M
Operating Cash Flow-11.21M-23.53M-81.40M-40.60M-129.00K
Investing Cash Flow-761.00K-59.00K-1.60M-2.00M-1.06M
Financing Cash Flow16.04M28.91M-900.00K120.60M6.46M

Owlet Technical Analysis

Technical Analysis Sentiment
Positive
Last Price8.12
Price Trends
50DMA
6.55
Positive
100DMA
5.26
Positive
200DMA
5.00
Positive
Market Momentum
MACD
0.56
Positive
RSI
55.19
Neutral
STOCH
19.63
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For OWLT, the sentiment is Positive. The current price of 8.12 is below the 20-day moving average (MA) of 8.13, above the 50-day MA of 6.55, and above the 200-day MA of 5.00, indicating a neutral trend. The MACD of 0.56 indicates Positive momentum. The RSI at 55.19 is Neutral, neither overbought nor oversold. The STOCH value of 19.63 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for OWLT.

Owlet Risk Analysis

Owlet disclosed 76 risk factors in its most recent earnings report. Owlet reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Owlet Peers Comparison

Overall Rating
UnderperformOutperform
Sector (50)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
$138.81M60.56%45.51%49.64%
60
Neutral
$102.47M-16.53%-4.15%3.49%
53
Neutral
$62.27M-67.86%0.34%6.20%
50
Neutral
AU$2.51B3.43-57.47%2.67%36.73%13.67%
48
Neutral
$65.11M-94.65%-5.86%50.76%
48
Neutral
$86.37M-26.20%20.81%-498.66%
44
Neutral
$442.65M-29.16%25.77%49.44%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
OWLT
Owlet
8.03
3.44
74.95%
ICAD
iCAD
3.87
2.51
184.56%
CTSO
Cytosorbents
0.99
-0.05
-4.81%
XTNT
Xtant Medical Holdings
0.62
-0.12
-16.22%
BFLY
Butterfly Network
1.85
0.67
56.78%
HYPR
Hyperfine
1.03
-0.21
-16.94%

Owlet Corporate Events

Private Placements and FinancingBusiness Operations and Strategy
Owlet Amends Credit Agreement to Boost Flexibility
Positive
Jun 16, 2025

On June 11, 2025, Owlet, Inc. and its subsidiary Owlet Baby Care, Inc. entered into a First Amendment to their Credit and Security Agreement with financial institutions and ABL OPCO LLC. This amendment modifies financial covenants, increases allowable capital expenditures, and expands borrowing eligibility against certain accounts receivable, potentially enhancing the company’s financial flexibility and operational capacity.

The most recent analyst rating on (OWLT) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Owlet stock, see the OWLT Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 10, 2025